Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

NCT00605566 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: Sorafenib
DRUG: Cyclophosphamide

Sponsor

University Health Network, Toronto